Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 820027 MINNEAPOLIS, MN
Back to RYTM Full portfolio

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$44,593,421
+$11,200,683 QoQ
Shares Held
401,634
+4.6% QoQ
Ownership
0.583%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
18 quarters on record
Voting authority Sole 0% Shared 88% None 12%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. RYTM ranks #20 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,604,822 $1,293,893,227
2 INSM
INSMED Inc
 6,179,571 $658,865,856
3 JAZZ
Jazz Pharmaceuticals plc
 1,215,523 $292,904,576
4 RVMD
Revolution Medicines, Inc.
 1,039,702 $194,715,388
5 ARGX
Argenx SE
 181,464 $168,356,853
6 REGN
Regeneron Pharmaceuticals, Inc.
 227,457 $141,828,535
7 MDGL
Madrigal Pharmaceuticals, Inc.
 231,205 $124,145,521
8 BBIO
BridgeBio Pharma, Inc.
 1,551,663 $115,567,858

All Filings in RYTM

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,593,421 401,634
2026-03-31 $33,392,738 383,957
2025-12-31 $27,954,565 261,160
2025-09-30 $13,933,286 137,967
2025-06-30 $10,936,229 173,069
2025-03-31 $5,205,944 98,281
2024-12-31 $2,987,483 53,367
2024-09-30 $2,194,459 41,887
2024-06-30 $1,659,439 40,415
2024-03-31 $909,063 20,980
2023-12-31 $964,450 20,980
2023-09-30 $503,891 21,980
2023-06-30 $299,128 18,140
2023-03-31 $323,617 18,140
2022-12-31 $528,236 18,140
2022-09-30 $444,430 18,140
2022-06-30 $75,281 18,140
2020-12-31 $250,029 8,410